FIRAZYR

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, United Kingdom, United States

Active ingredients

The drug FIRAZYR contains one active pharmaceutical ingredient (API):

1 Icatibant UNII 325O8467XK - ICATIBANT ACETATE

Icatibant is a selective competitive antagonist at the bradykinin type 2 (B2) receptor. It is a synthetic decapeptide with a structure similar to bradykinin, but with 5 non-proteinogenic amino acids. In HAE increased bradykinin concentrations are the key mediator in the development of the clinical symptoms. Read about Icatibant

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
FIRAZYR Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B06AC02	Icatibant	B Blood and blood forming organs → B06 Other hematological agents → B06A Other hematological agents → B06AC Drugs used in hereditary angioedema
Discover more medicines within B06AC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 501121040039017
Country: CA	Health Products and Food Branch	Identifier(s): 02425696
Country: EE	Ravimiamet	Identifier(s): 1381632, 1523607
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 08461001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 146529
Country: FR	Base de données publique des médicaments	Identifier(s): 61680479
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 150324
Country: HK	Department of Health Drug Office	Identifier(s): 66935
Country: IE	Health Products Regulatory Authority	Identifier(s): 88148
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6312
Country: JP	医薬品医療機器総合機構	Identifier(s): 4490406G1029
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1033654, 1063755
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 128635
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 17717
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100218256
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68202001
Country: US	FDA, National Drug Code	Identifier(s): 54092-702